Shanghai Ark Biopharmaceutical
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (19)
A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants
Started: 2/29/2024
A Study of AK0529 in Chinese Infants Hospitalized With RSV
Started: 9/22/2020
A Study to Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD
Started: 5/28/2024
A Phase 3 Study of Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis
Started: 8/31/2026
A Study of Ziresovir (AK0529) in High-risk Adult With Respiratory Syncytial Virus (RSV) Infection.
Started: 3/3/2026
A Study of AK0529 in Adults Patients Hospitalized With RSV Infection
Started: 7/20/2023
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AK0406 Injection in Healthy Adult Participants
Started: 2/1/2026
Thorough QT/QTc (TQT) Clinical Study to Evaluate the Effects of Ziresovir on Cardiac Repolarization in Healthy Subjects
Started: 9/25/2024
A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Ziresovir in Healthy Subjects
Started: 3/24/2021
A Study of AK0529 to Evaluate Pharmacokinetics and Safety in Chinese Healthy Volunteers
Started: 10/23/2017
A Study to Assess the Effect of AK3280 on Renal Function in Healthy Subjects
Started: 10/3/2019
A Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of AK0529
Started: 1/5/2018
A Study of AK0529 in Infants Hospitalized With RSV
Started: 8/28/2015
Safety, Tolerability and PK Study of AK0529 in Healthy Human
Started: 10/1/2014
A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar
Started: 7/8/2022